Xenon Pharmaceuticals XENE
NASDAQ XENE
$39.41 +2.22 (+5.97%)
As of: Oct 1, 2026 · 11:59 AM EDT

Xenon Pharmaceuticals (XENE) Other Non-Current Liabilities (2013 - 2026)

Updated

Xenon Pharmaceuticals' Other Non-Current Liabilities was $3.29 million in Q2 2026, up 1.3% from the prior quarter.

Analysis

Xenon Pharmaceuticals (XENE) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends

At the end of FY2025, Other Non-Current Liabilities at Xenon Pharmaceuticals came in at $3.2 million.

  • The Q2 2026 figure marks the highest quarterly Other Non-Current Liabilities in data going back to Q4 2013.
  • Per Business Quant data, XENE's Other Non-Current Liabilities in the three quarters before Q2 2026 was $3.25 million (Q1 2026), $3.2 million (Q4 2025) and $3.16 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Xenon Pharmaceuticals 3.60 Bn 3.60 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.29 Mn
Mar 31, 2026 3.25 Mn
Dec 31, 2025 3.20 Mn
Sep 30, 2025 3.16 Mn
Jun 30, 2015 164,000.00
Mar 31, 2015 180,000.00
Dec 31, 2014 196,000.00
Sep 30, 2014 219,000.00
Dec 31, 2013 282,000.00
API Access

Xenon Pharmaceuticals Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=XENE&period=max&api_key=YOUR_API_KEY